ALFUZOSINE LP EVOLUGEN 10 mg

Generic drug of Xatral LP
Therapeutic class: Urology nephrology
active ingredients: Alfuzosin
laboratory: Evolupharm

Extended release film-coated tablet
Box of 30
All forms

Indication

· Treatment of functional symptoms of benign prostatic hypertrophy.

· Adjunctive bladder catheterization in acute urine retention related to benign prostatic hypertrophy.

Oral way.

The tablet should be swallowed whole with a glass of water (see Warnings and Precautions ).

The recommended dosage is 1 10 mg tablet daily, to be taken immediately after the evening meal.

Adjuvant bladder catheterization in acute urine retention related to benign prostatic hypertrophy:

The recommended dosage is 1 10 mg tablet daily, to be taken after the meal, from the first day of urethral catheterization.

The treatment is administered for 3 to 4 days including 2 to 3 days during the catheterization and 1 day after the withdrawal of the latter.

This product should not be administered in the following situations:

Hypersensitivity to alfuzosin and / or any of the other ingredients;

· orthostatic hypotension ;

· Hepatic insufficiency ;

· Severe renal impairment (creatinine clearance <30 ml / min);

FREQUENCY
ORGAN SYSTEM	Frequent (≥ 1% - <10%)	Rare (≥ 0.1% - <1%)	Very rare (<0.01%)
CNS disorders and psychiatric disorders	dizziness, dizziness, malaise, headache	dizziness, drowsiness
Cardiovascular disorders		tachycardia, palpitations, orthostatic hypotension, syncope	Angina pectoris in patients with a history of coronary heart disease (see Warnings and Precautions section )
Respiratory system disorders		Nasal congestion

Gastrointestinal disorders	nausea, abdominal pain	diarrhea, dry mouth
Skin manifestations		rashes, pruritus	Urticaria, angioneurotic edema
General events	asthenia	flushes, edema, chest pain (see section Warnings and precautions for use )